This article discusses the challenges, recent developments and new
thinking on drug R&D for neglected diseases through public-private
partnerships. The focus on virtual drug discovery and development as
operationalized through these partnerships brings many advantages, as
well as scientific and managerial challenges. Some are common to those
faced by all drug R&D ventures. Others, for example the need for
drugs with a very low cost of manufacture that are easy to use in
resource-poor environments and an active engagement in disease-endemic
countries, are unique to this novel paradigm.
Nwaka, S.; Ridley, R.G. Science & society: Virtual drug discovery and development for neglected diseases through public&#8211;private partnerships. Nature Reviews Drug Discovery (2003) 2 (11) 919-928. [DOI: 10.1038/nrd1230]
Virtual drug discovery and development for neglected diseases through public-private partnerships.